Overview Financials News + Filings Key Docs Ownership Insiders
|
|
NP Life Sciences Health Industry Group Inc. (GJCU)
|
|
| Income Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | 10-K |
| Revenues: |
| Customer B | | | 0.0 |
| Customer A | | | 0.0 |
| Total revenues | 0.0 | 0.0 | 0.0 |
| Revenue growth | 133.3% | -65.1% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative [+] | 0.1 | 0.1 | 0.2 |
| General and administrative | 0.1 | 0.1 | 0.2 |
| EBITA | -0.1 | -0.1 | -0.1 |
| EBITA margin | -187.7% | -863.5% | -249.8% |
| Amortization of intangibles | | 0.0 | 0.0 |
| EBIT [+] | -0.1 | -0.1 | -0.1 |
| EBIT growth | -49.9% | 20.4% | |
| EBIT margin | -187.7% | -873.9% | -253.2% |
| Interest income | 0.0 | 0.0 | 0.0 |
| Interest income | 0.0 | 0.0 | 0.0 |
| Pre-tax income | -0.1 | -0.1 | -0.1 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -0.1 | -0.1 | -0.1 |
| Net margin | -187.7% | -873.8% | -253.1% |
| |
| Basic EPS [+] | $0.00 | $0.00 | $0.00 |
| Growth | -49.9% | -4.3% | |
| Diluted EPS [+] | $0.00 | $0.00 | $0.00 |
| Growth | -49.9% | -4.3% | |
| |
| Shares outstanding (basic) [+] | 43.0 | 43.0 | 34.1 |
| Growth | 0.0% | 25.9% | |
| Shares outstanding (diluted) [+] | 43.0 | 43.0 | 34.1 |
| Growth | 0.0% | 25.9% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|